Cargando…

Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function

Type 2 diabetes mellitus (T2DM) is a known independent risk factor for atherosclerotic cardiovascular disease (CVD) and solid epidemiological evidence points to heart failure (HF) as one of the most common complications of diabetes. For this reason, it is imperative to consider the prevention of CV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salvatore, Teresa, Caturano, Alfredo, Galiero, Raffaele, Di Martino, Anna, Albanese, Gaetana, Vetrano, Erica, Sardu, Celestino, Marfella, Raffaele, Rinaldi, Luca, Sasso, Ferdinando Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533063/ https://www.ncbi.nlm.nih.gov/pubmed/34680473 http://dx.doi.org/10.3390/biomedicines9101356

Ejemplares similares

Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence
por: Salvatore, Teresa, et al.
Publicado: (2021)

Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations
por: Galiero, Raffaele, et al.
Publicado: (2023)

Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes
por: Salvatore, Teresa, et al.
Publicado: (2022)

Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes
por: Salvatore, Teresa, et al.
Publicado: (2022)

Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options
por: Salvatore, Teresa, et al.
Publicado: (2022)

An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors
por: Salvatore, Teresa, et al.
Publicado: (2022)

Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study
por: Caturano, Alfredo, et al.
Publicado: (2023)

The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
por: Salvatore, Teresa, et al.
Publicado: (2021)

Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study
por: Caturano, Alfredo, et al.
Publicado: (2023)

Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?
por: Salvatore, Teresa, et al.
Publicado: (2020)

HCC and Molecular Targeting Therapies: Back to the Future
por: Rinaldi, Luca, et al.
Publicado: (2021)

Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies
por: Vetrano, Erica, et al.
Publicado: (2023)

Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice
por: Cesaro, Arturo, et al.
Publicado: (2023)

Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options
por: Galiero, Raffaele, et al.
Publicado: (2023)

The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2022)

Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications
por: Caturano, Alfredo, et al.
Publicado: (2023)

Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects
por: Palmiero, Giuseppe, et al.
Publicado: (2021)

Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2021)

Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2019)

Metformin: A Potential Therapeutic Tool for Rheumatologists
por: Salvatore, Teresa, et al.
Publicado: (2020)

Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review
por: Rinaldi, Luca, et al.
Publicado: (2021)

The Role of Neuropathy Screening Tools in Patients Affected by Fibromyalgia
por: Galiero, Raffaele, et al.
Publicado: (2022)

The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy
por: Galiero, Raffaele, et al.
Publicado: (2020)

Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic Subjects
por: Pafundi, Pia Clara, et al.
Publicado: (2021)

GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives
por: Nevola, Riccardo, et al.
Publicado: (2023)

Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis
por: Cuomo, Giovanna, et al.
Publicado: (2023)

Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study
por: Galiero, Raffaele, et al.
Publicado: (2020)

Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study
por: Pafundi, Pia Clara, et al.
Publicado: (2021)

Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome
por: Cozzolino, Domenico, et al.
Publicado: (2023)

Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence
por: Sardu, Celestino, et al.
Publicado: (2020)

Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up
por: Sardu, Celestino, et al.
Publicado: (2021)

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
por: Caturano, Alfredo, et al.
Publicado: (2019)

MiR-15b-5p and PCSK9 inhibition reduces lipopolysaccharide-induced endothelial dysfunction by targeting SIRT4
por: Martino, Elisa, et al.
Publicado: (2023)

Gliflozine – in Zukunft Kardioprotektiva?
por: Rauch-Kröhnert, Ursula, et al.
Publicado: (2021)

COVID-19 and Its Cardiovascular Effects: Risk Factors, Prevention and Management
por: Sardu, Celestino, et al.
Publicado: (2023)

Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19
por: Sardu, Celestino, et al.
Publicado: (2020)

Evidence for human diabetic cardiomyopathy
por: Marfella, Raffaele, et al.
Publicado: (2021)

Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism?
por: Fontanella, Rosaria Anna, et al.
Publicado: (2021)

SIRT3 mediates the effects of PCSK9 inhibitors on inflammation, autophagy, and oxidative stress in endothelial cells
por: D'Onofrio, Nunzia, et al.
Publicado: (2023)

Could Anti‐Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID‐19 Infection? Data From Centers of Southern Italy
por: Sardu, Celestino, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mdjm856els07c8g6uivbcdmno7